Abstract
Among the clinical symptoms of coronavirus disease 2019 (COVID-19), acute respiratory dysfunction syndrome (ARDS) is the most rapid and fatal form of clinical symptoms, and since conventional treatment cannot achieve satisfactory results, extracorporeal membrane oxygenation (ECMO) can be tried. We report two cases, one of the COVID-19 patients who received ECMO treatment for ARDS at Soonchunhyang University Bucheon Hospital received long-term ECMO treatment but improved without any complications, and one patient who received ECMO treatment for viral myocarditis rapidly deteriorated and died. We describe ECMO treatment in COVID-19 through the two cases mentioned above. Key words: COVID-19; Extracorporeal membrane oxygenation; Acute respiratory dysfunction syndrome; Myocarditis
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
